Exclusive: RedHill BioPharma CEO Talks Steering His Company Through A Year Heavy With Potential Catalysts
June 05, 2017 at 15:54 PM EDT
If investors were to sum up the year 2017 for specialty drug maker RedHill Biopharma Ltd - ADR (NASDAQ: RDHL) in one phrase, it might be ...
